Forbes -
6 Apr 2016 17:46
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Alexion Pharmaceuticals (ALXN) is now the #59 analyst pick, moving up by 2 spots.
Share this Article
Comment on this Article
Please to comment